Las Vegas, NV -- (SBWIRE) -- 12/30/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Galena Biopharma Inc (NASDAQ:GALE), Kinross Gold Corporation (USA) (NYSE:KGC), Gevo, Inc. (NASDAQ:GEVO)
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) managed to keep its gain at 3.32% on above-normal volume of 3.06M shares. The stock settled at $0.517 after floating in a range of $0.49 to $0.53. Its latest price has reached market capitalization of $75.79 million. Its 52-week range has been $0.28 to $0.66. Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company.
For How Long RNN will fight for Profitability? Read This Trend Analysis report
Galena Biopharma Inc (NASDAQ:GALE) traded up on a volume of 5.18 million, lower than its standard daily volume. Shares have gained 5.41% to $4.29. Over the last twelve months, the stock has gained 186% and faced a worst price of $1.48. Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche).
For How Long GALE’s Gloss will Attract Investors? Find out via this report
Kinross Gold Corporation (USA) (NYSE:KGC) settled 0.92% higher at $4.40 on above-normal volume of 15.36M shares during the last trading day. The stock has its 12-month high at $9.99 and 52-week low price was $4.24. It traded in a range of $4.34 to $4.42 during the last trading day. Kinross Gold Corporation (Kinross) is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties. Kinross also produces and sells silver. Kinross’ gold production and exploration activities are carried out principally in Canada, the United States, the Russian Federation, Brazil, Ecuador, Chile, Ghana and Mauritania.
Why Should Investors Buy KGC After the Recent Fall? Just Go Here and Find Out
In the last trading session, Gevo, Inc. (NASDAQ:GEVO) was up on high volume, trading at a volume of 3.04M shares versus its average daily volume of 2.10 million shares. At $1.39, the stock has attained market capitalization of $65.59 million. Gevo, Inc., is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.
Will GEVO Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)